Mal de débarquement

Mal de débarquement (MdD), also known as Mal de débarquement syndrome (MdDS) or disembarkment syndrome, is a rare neurological condition characterized by a persistent sensation of rocking, swaying, or bobbing that typically begins after exposure to passive motion, such as travel by boat, airplane, car, or train. The condition primarily affects the vestibular and neurological systems. Unlike the brief, self-limiting sensation of continued motion that many people experience after travel, MdDS persists for months or even years. In some cases, the condition can arise spontaneously without a preceding motion event. The hallmark symptom is a phantom perception of self-motion, often described as feeling as though one is still on a boat. Patients frequently report that symptoms temporarily improve during actual passive motion (such as riding in a car) and worsen when stationary. Key symptoms include chronic rocking or swaying sensations, imbalance, difficulty concentrating (brain fog), fatigue, and spatial disorientation. Many patients also experience anxiety, depression, and visual sensitivity, which can significantly impair quality of life. The condition predominantly affects women, typically in their 30s to 50s. Standard vestibular testing is often normal, which can lead to diagnostic delays. The pathophysiology is not fully understood but is thought to involve maladaptation of the vestibulo-ocular reflex and abnormal processing in velocity storage mechanisms of the brainstem and cerebellum. There is currently no universally effective treatment for MdDS. Management strategies include vestibular rehabilitation therapy, benzodiazepines (such as clonazepam), and selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) for symptom management. A promising experimental approach involves readaptation protocols using optokinetic stimulation to reset the velocity storage mechanism. Cognitive behavioral therapy may help patients cope with the psychological burden of the condition. Research into transcranial magnetic stimulation (TMS) and other neuromodulation techniques is ongoing.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Mal de débarquement